Listen to The Lancet Haematology

Mar 03 2025 53 ep. 14 mins 762
Listen to The Lancet Haematology Podcast artwork

The Lancet Haematology launched in Autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice.

  Education
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


In conversation with... Helene Schoemans, Elke Stienissen, and Kathy Goris

Mar 03 2025 27 mins  
Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe.

In conversation with... Dawn Swan

Jan 29 2025 15 mins  
Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism.

In conversation with... Leslie Skeith

Jan 16 2025 16 mins  
Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism.

In conversation with... Neema Mayor and Caitlin Farrow

Dec 04 2024 17 mins  
Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom.

Lancet Haematology 10 year anniversary - meet the editors

Oct 02 2024 47 mins  
In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology, reflect on the last decade and give some insights into the editorial processes at The Lancet Group.

In conversation with... Matteo Giovanni Della Porta

Aug 22 2024 8 mins  
Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients.

In conversation with... Kim Linton

Aug 07 2024 9 mins  
Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.

In conversation with... Judy Truong

Aug 05 2024 11 mins  
Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine.

In conversation with... Johannes Schetelig

Dec 31 1969 14 mins  
Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia.

In conversation with... Banu Aygun

May 23 2024 11 mins  
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa.